Kolb H J, Bender-Götze C, Holler E, Mittermüller J, Grosse-Wilde H, Wank R, Eckstein R, Scholz S, Haas R J, Mempel W
Medizinische Klinik III, Klinikum Grosshadern, Universität München.
Folia Haematol Int Mag Klin Morphol Blutforsch. 1989;116(3-4):421-5.
In most centers allogeneic bone marrow transplantation is restricted to patients with HLA-identical siblings as donors. We have transplanted 16 patients with marrow of donors other than HLA-identical siblings. Seven patients were grafted in the years 1978 until 1984. Six died of transplant complications and one of recurrent leukemia. More recently 9 patients were transplanted following an improved immunosuppressive conditioning treatment derived from experimental studies in dogs. Four are alive and in continuous remission between more than 2 months and 2 years. 5 patients died, 3 from fungal infections, one from recurrent leukaemia and one early from endothelial leakage syndrome. Our results indicate that intensified immunosuppressive conditioning may improve the results of marrow transplantation from HLA-haploidentical donors.
在大多数医疗中心,异基因骨髓移植仅限于供体为 HLA 配型相同的同胞的患者。我们已为 16 名患者进行了非 HLA 配型相同同胞供体的骨髓移植。1978 年至 1984 年间有 7 名患者接受了移植。其中 6 名死于移植并发症,1 名死于复发性白血病。最近,9 名患者在经过源于犬类实验研究的改良免疫抑制预处理后接受了移植。4 名患者存活,处于超过 2 个月至 2 年的持续缓解状态。5 名患者死亡,3 名死于真菌感染,1 名死于复发性白血病,1 名早期死于内皮渗漏综合征。我们的结果表明,强化免疫抑制预处理可能会改善 HLA 单倍型相合供体骨髓移植的效果。